Amneal Pharmaceuticals (AMRX) Cash from Investing Activities Growth (1y) (2018 - 2026)
Amneal Pharmaceuticals (AMRX) Cash from Investing Activities Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -308.05% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -41.51% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -139.86% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 129.18% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.71% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -366.90% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -96.43% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Amneal Pharmaceuticals | 5.70 Bn | 5.57 Bn | 334.51 Mn | -362.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -362.36% |
| Mar 31, 2026 | -21.98% |
| Dec 31, 2025 | -183.04% |
| Sep 30, 2025 | -8.46% |
| Jun 30, 2025 | -310.63% |
| Mar 31, 2025 | 9.93% |
| Dec 31, 2024 | 49.33% |
| Sep 30, 2024 | -53.70% |
| Jun 30, 2024 | 47.37% |
| Mar 31, 2024 | -68.36% |
| Dec 31, 2023 | -176.40% |
| Sep 30, 2023 | 72.68% |
| Jun 30, 2023 | 23.78% |
| Mar 31, 2023 | 87.95% |
| Dec 31, 2022 | 86.82% |
| Sep 30, 2022 | -324.07% |
| Jun 30, 2022 | 80.56% |
| Mar 31, 2022 | -667.31% |
| Dec 31, 2021 | -173.53% |
| Sep 30, 2021 | 21.30% |